| . | Mean . | Locality Range . |
|---|---|---|
| Population characteristics | ||
| Households sampled (%) | 94.2 | 90.8–100.0 |
| N eligible | 2310 | 272–646 |
| N sampled | 2082 | 233–635 |
| Sex (% male) | 45.3 | 43.1–47.3 |
| Reported net use | 71.5 | 53.4–77.4 |
| Parasite metric | ||
| nPCR prevalence | 23.5 | 11.7–38.9 |
| <5 | 17.3 | 9.8–32.1 |
| 5–15 | 35.3 | 14.0–59.5 |
| >15 | 16.4 | 8.2–25.5 |
| MSP2–MOIa | 2.22 | 1.61–2.61 |
| <5 | 2.24 | 1.33–2.60 |
| 5–15 | 2.34 | 1.54–2.81 |
| >15 | 1.95 | 1.72–2.23 |
| . | Mean . | Locality Range . |
|---|---|---|
| Population characteristics | ||
| Households sampled (%) | 94.2 | 90.8–100.0 |
| N eligible | 2310 | 272–646 |
| N sampled | 2082 | 233–635 |
| Sex (% male) | 45.3 | 43.1–47.3 |
| Reported net use | 71.5 | 53.4–77.4 |
| Parasite metric | ||
| nPCR prevalence | 23.5 | 11.7–38.9 |
| <5 | 17.3 | 9.8–32.1 |
| 5–15 | 35.3 | 14.0–59.5 |
| >15 | 16.4 | 8.2–25.5 |
| MSP2–MOIa | 2.22 | 1.61–2.61 |
| <5 | 2.24 | 1.33–2.60 |
| 5–15 | 2.34 | 1.54–2.81 |
| >15 | 1.95 | 1.72–2.23 |
Demographics of the study population, including the number of people sampled overall, the range of values per locality and for parasite metrics, the 95% confidence interval was computed.
Abbreviations: MOI, multiplicity of infection; MSP2, merozoite surface protein-2; nPCR, nested polymerase chain reaction.
a N = 489 nPCR positive.
| . | Mean . | Locality Range . |
|---|---|---|
| Population characteristics | ||
| Households sampled (%) | 94.2 | 90.8–100.0 |
| N eligible | 2310 | 272–646 |
| N sampled | 2082 | 233–635 |
| Sex (% male) | 45.3 | 43.1–47.3 |
| Reported net use | 71.5 | 53.4–77.4 |
| Parasite metric | ||
| nPCR prevalence | 23.5 | 11.7–38.9 |
| <5 | 17.3 | 9.8–32.1 |
| 5–15 | 35.3 | 14.0–59.5 |
| >15 | 16.4 | 8.2–25.5 |
| MSP2–MOIa | 2.22 | 1.61–2.61 |
| <5 | 2.24 | 1.33–2.60 |
| 5–15 | 2.34 | 1.54–2.81 |
| >15 | 1.95 | 1.72–2.23 |
| . | Mean . | Locality Range . |
|---|---|---|
| Population characteristics | ||
| Households sampled (%) | 94.2 | 90.8–100.0 |
| N eligible | 2310 | 272–646 |
| N sampled | 2082 | 233–635 |
| Sex (% male) | 45.3 | 43.1–47.3 |
| Reported net use | 71.5 | 53.4–77.4 |
| Parasite metric | ||
| nPCR prevalence | 23.5 | 11.7–38.9 |
| <5 | 17.3 | 9.8–32.1 |
| 5–15 | 35.3 | 14.0–59.5 |
| >15 | 16.4 | 8.2–25.5 |
| MSP2–MOIa | 2.22 | 1.61–2.61 |
| <5 | 2.24 | 1.33–2.60 |
| 5–15 | 2.34 | 1.54–2.81 |
| >15 | 1.95 | 1.72–2.23 |
Demographics of the study population, including the number of people sampled overall, the range of values per locality and for parasite metrics, the 95% confidence interval was computed.
Abbreviations: MOI, multiplicity of infection; MSP2, merozoite surface protein-2; nPCR, nested polymerase chain reaction.
a N = 489 nPCR positive.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
